NCT02297802No Longer Available不适用
A Phase I Single Patient IND for PD-0325901
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Prior treatment with PD-0325901 with ongoing response
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
SINGLE PATIENT EXPANDED ACCESS OF A PROSPECTIVE, MULTICENTER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND PROBABLE BENEFIT OF THE KERAKLEAR NON-PENETRATING KERATOPROSTHESIS IN SUBJECTS WITH CORNEAL OPACITY WITH POOR PROGNOSIS FOR CORNEAL TRANSPLANTCORNEAL OPACITY WITH POOR PROGNOSIS FOR CORNEAL TRANSPLANTNCT03812341University of California, Irvine
No Longer Available
不适用
Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple MyelomaMultiple MyelomaNCT04452994Janssen Research & Development, LLC
No Longer Available
不适用
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of PembrolizumabNCT04135092National Institutes of Health Clinical Center (CC)
Approved For Marketing
不适用
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access ProtocolCardiomyopathiesHeart FailureNCT01242891Berlin Heart, Inc
已完成
1 期
Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy SubjectsNormal HealthyNCT02871037Pfizer96